Page last updated: 2024-11-06

prednisolone and Cancer of Endometrium

prednisolone has been researched along with Cancer of Endometrium in 5 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Research Excerpts

ExcerptRelevanceReference
"Individuals presenting with ovarian or endometrial cancer received four or five weekly doses of 1."2.67Treatment of cancer patients with a low-density-lipoprotein delivery vehicle containing a cytotoxic drug. ( Akerlund, M; Breeze, A; Filipowska, D; Filipowski, T; Kazanowska, W; Lapinjoki, S; Laudanski, T; Morelowska, B, 1992)
"A 71-year-old female with advanced endometrial cancer was treated with pegfilgrastim."1.51Large-vessel vasculitis associated with PEGylated granulocyte-colony stimulating factor. ( Hirata, S; Mokuda, S; Sugiyama, E; Yoshida, Y; Yukawa, K, 2019)
"The association of systemic lupus erythematosus (SLE) and solid tumors is infrequent."1.29[A dual occurrence of endometrial and gastric adenocarcinomas in systemic lupus erythematosus]. ( Akama, T; Iijima, T; Kashiwagi, H; Nakahara, A; Suzuki, H; Takemura, H; Yamane, K; Yuhara, T, 1996)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yukawa, K1
Mokuda, S1
Yoshida, Y1
Hirata, S1
Sugiyama, E1
Kasuya, A1
Hamaguchi, Y1
Fujimoto, M1
Tokura, Y1
Saito, W1
Kase, S1
Yoshida, K1
Ohguro, H1
Yokoi, M1
Iwaki, H1
Ohno, S1
Yamane, K1
Iijima, T1
Nakahara, A1
Takemura, H1
Yuhara, T1
Akama, T1
Suzuki, H1
Kashiwagi, H1
Filipowska, D1
Filipowski, T1
Morelowska, B1
Kazanowska, W1
Laudanski, T1
Lapinjoki, S1
Akerlund, M1
Breeze, A1

Trials

1 trial available for prednisolone and Cancer of Endometrium

ArticleYear
Treatment of cancer patients with a low-density-lipoprotein delivery vehicle containing a cytotoxic drug.
    Cancer chemotherapy and pharmacology, 1992, Volume: 29, Issue:5

    Topics: Adenocarcinoma; Adrenal Cortex; Chenodeoxycholic Acid; Cystadenocarcinoma; Drug Carriers; Drug Thera

1992

Other Studies

4 other studies available for prednisolone and Cancer of Endometrium

ArticleYear
Large-vessel vasculitis associated with PEGylated granulocyte-colony stimulating factor.
    The Netherlands journal of medicine, 2019, Volume: 77, Issue:6

    Topics: Aged; Aorta, Thoracic; Endometrial Neoplasms; Female; Filgrastim; Giant Cell Arteritis; Glucocortico

2019
TIF1γ-overexpressing, highly progressive endometrial carcinoma in a patient with dermato-myositis positive for malignancy-associated anti-p155/140 autoantibody.
    Acta dermato-venereologica, 2013, Volume: 93, Issue:6

    Topics: Anti-Inflammatory Agents; Autoantibodies; Carcinoma; Dermatomyositis; Endometrial Neoplasms; Female;

2013
Bilateral diffuse uveal melanocytic proliferation in a patient with cancer-associated retinopathy.
    American journal of ophthalmology, 2005, Volume: 140, Issue:5

    Topics: Aged; Autoantibodies; Autoantigens; Blotting, Western; Cell Proliferation; Electroretinography; Endo

2005
[A dual occurrence of endometrial and gastric adenocarcinomas in systemic lupus erythematosus].
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 1996, Volume: 19, Issue:3

    Topics: Adenocarcinoma; Anti-Inflammatory Agents; Endometrial Neoplasms; Female; Humans; Lupus Erythematosus

1996